Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2020-06-24 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Transaction in Own Shares Classification · 95% confidence The document is an announcement related to a general mandate granted to the board to repurchase H shares of the company. It includes instructions for creditors to submit claims and details about the process. The document references regulatory disclosure requirements under the Hong Kong Stock Exchange rules and is titled as an "Overseas Regulatory Announcement." It does not contain financial statements or detailed financial data but rather serves as a formal notification to creditors and the public about the repurchase mandate and creditor claims. The length is just over 5,000 characters but the content is clearly an announcement rather than a full report. Therefore, it fits best under the category of Transaction in Own Shares (POS), as it concerns the company's share repurchase mandate and related creditor notification.
2020-06-24 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 23, 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on June 23, 2020, for CStone Pharmaceuticals. It details the voting outcomes on various resolutions including re-election of directors, appointment of auditors, and share option grants. The document does not contain the full AGM materials or presentations but reports the official voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is 6432 characters, which is sufficient for a detailed voting result announcement but not a full AGM report or presentation. Therefore, the correct classification is DVA with high confidence.
2020-06-23 English
VOLUNTARY ANNOUNCEMENT - CSTONE RELEASED PRECLINICAL DATA ON ITS FOUR PIPELINE PRODUCTS
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals about the release of preclinical data on its four pipeline products. It discusses scientific and clinical development updates, including presentations at a scientific meeting (AACR) and publication of a peer-reviewed article. There is no indication that this is a financial report, earnings release, regulatory filing, or any formal report type such as Annual Report or Interim Report. The document is an announcement of scientific data release and company pipeline progress, not a financial or governance filing. It is not a report publication announcement since it contains substantive information about the data and clinical development. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories like earnings, management changes, or capital updates.
2020-06-23 English
SECOND ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under the Hong Kong Stock Exchange rules. It relates to a general mandate granted to the board to repurchase H shares and includes instructions for creditors to submit claims. The content is regulatory in nature, informing stakeholders about the repurchase mandate and creditor claims process, but it does not contain financial statements or detailed financial data. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or management report. It is also not a simple report publication announcement since it contains substantive regulatory information. The document fits best as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories such as Capital/Financing Update or Transaction in Own Shares, as it is more about the announcement of the mandate and creditor claims rather than the execution of repurchase or financing activity.
2020-06-22 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2020 FIRST CLASS MEETING OF THE HOLDERS OF A SHARES AND THE RESOLUTIONS PASSED AT THE 2020 FIRST CLASS MEETING OF THE HOLDERS OF H SHARES
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement detailing the resolutions passed at the 2020 first class meetings of holders of A shares and H shares of Yanzhou Coal Mining Company Limited. It includes information about the convening of the meetings, attendance, voting results, compliance with laws and regulations, presence of scrutineers and lawyers, and legal opinions confirming the validity of the meetings and voting. The document does not contain financial statements or detailed financial performance data but focuses on the official results of shareholder votes at these class meetings. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 11,000 characters, indicating it is a full announcement rather than a brief notice or a report publication announcement.
2020-06-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-06-19 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.